GlassScriptPhysician profile
Tracy B Fausnight
NPI 1194779512
$9,100.14
in general payments reported to CMS, 2019-2025
17 companies · $153 in 2025
The $153 reported for 2025 was less than what a typical Pediatric Allergy/Immunology provider received nationally (typical 2025 total: $375).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $321 · 2020: $39.19 · 2022: $8,009 · 2023: $241 · 2024: $336 · 2025: $153.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $636 · Education: $94.66.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $635.69 |
| Education | $94.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $7,777.70 | 2022-2025 | Takhzyro |
| Genzyme Corporation | $325.30 | 2019-2024 | |
| Pharming Healthcare, INC. | $194.88 | 2019-2025 | Ruconest |
| Pfizer INC. | $123.35 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $117.37 | 2019 | |
| Genentech, INC. | $115.04 | 2023-2024 | Xolair |
| Regeneron Healthcare Solutions, INC. | $106.76 | 2019-2024 | Dupixent |
| Amgen INC. | $77.62 | 2024 | Actimmune |
| Blueprint Medicines Corporation | $52.17 | 2024 | Ayvakit |
| Sumitomo Pharma America, INC. | $50.00 | 2023 | Rethymic |
| Chiesi USA, INC. | $49.10 | 2022 | |
| Horizon Therapeutics Plc | $44.88 | 2023 | Actimmune |
| Csl Behring | $20.99 | 2020 | |
| Alk-Abello, INC | $18.20 | 2020 | |
| Shire North American Group INC | $15.81 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $10.97 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracy Fausnight listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.